Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127622432 | 12762243 | 2 | F | 20160920 | 20160920 | 20160928 | EXP | JP-BAYER-2016-180191 | BAYER | NEMOTO T, ITO Y, SAITO T, WATANABE J, TSUKAMOTO Y, KIKUCHI B, ET. AL.. A CASE OF REMOTE CEREBRAL HAEMORRHAGE DEVELOPING TWO WEEK AFTER THE TREATMENT WITH FLOW DIVERTER.. THE 34TH TOHOKU REGIONAL MEETING OF THE JAPANESE SOCIETY FOR NEUROENDOVASCULAR T. 2016;XXX:63 | 76.00 | YR | E | F | Y | 0.00000 | 20160928 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127622432 | 12762243 | 1 | PS | ACETYLSALICYLIC ACID({=100 mg) | ASPIRIN | 1 | Oral | DAILY DOSE 100 MG | Y | 21317 | 100 | MG | TABLET | ||||||
| 127622432 | 12762243 | 2 | SS | ACETYLSALICYLIC ACID({=100 mg) | ASPIRIN | 1 | Oral | DAILY DOSE 200 MG | Y | 21317 | 200 | MG | TABLET | ||||||
| 127622432 | 12762243 | 3 | SS | ACETYLSALICYLIC ACID({=100 mg) | ASPIRIN | 1 | Oral | DAILY DOSE 100 MG | Y | 21317 | 100 | MG | TABLET | ||||||
| 127622432 | 12762243 | 4 | SS | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | Oral | DAILY DOSE 75 MG | 0 | 75 | MG | TABLET | |||||||
| 127622432 | 12762243 | 5 | C | CILOSTAZOL. | CILOSTAZOL | 1 | Oral | DAILY DOSE 200 MG | 0 | 200 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127622432 | 12762243 | 1 | Cerebral endovascular aneurysm repair |
| 127622432 | 12762243 | 2 | Cerebral endovascular aneurysm repair |
| 127622432 | 12762243 | 3 | Cerebral endovascular aneurysm repair |
| 127622432 | 12762243 | 4 | Cerebral endovascular aneurysm repair |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127622432 | 12762243 | OT |
| 127622432 | 12762243 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127622432 | 12762243 | Aphasia | |
| 127622432 | 12762243 | Cerebral haemorrhage | |
| 127622432 | 12762243 | Drug administration error | |
| 127622432 | 12762243 | Hemiplegia | |
| 127622432 | 12762243 | Labelled drug-drug interaction medication error | |
| 127622432 | 12762243 | VIth nerve paralysis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |